Dotatate PET/CT and <sup>225</sup>Ac-Dotatate Therapy for Somatostatin Receptor–expressing Metastatic Breast Cancer
Gary A. Ulaner, Louis A. VanderMolen, Gary Li, Denis Gonçalves Ferreira
Abstract
Ac-Dotatate enables a new therapeutic option for patients with metastatic breast cancer. Clinical trial registration no. NCT05880394 © RSNA, 2024 See also the editorial by Lin and Choyke in this issue.
Topics & Concepts
MedicineSomatostatin receptorMetastatic breast cancerBreast cancerSomatostatinInternal medicineNuclear medicineOncologyCancerCancer researchNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesRadiopharmaceutical Chemistry and Applications